Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05977543
Other study ID # 12123
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 15, 2023
Est. completion date January 15, 2024

Study information

Verified date November 2023
Source University of the Aegean
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this interventional study was to investigate the postprandial effect of two types of functional crackers, with 10% grape seed flour or 40% barley flour, enriched with β-glucan, in metabolic biomarkers of healthy participants.


Description:

A pilot cross-over, controlled, randomized and single-blinded, intervention-clinical trial was carried out, in twelve healthy men and women, aged nineteen to sixty-five years, after random allocation into the control, the grape and the barley interventional groups, received a high-fat and high-carbohydrate meal, containing wheat flour or wheat and 10% grape seed flour or wheat and 40% barley flour, enriched with β-glucan, crackers. Participants consumed the same meals, allocating in cross-over order, with 1 washout week after each trial period. Differences on the metabolism of postprandial serum total, High Density Lipoprotein (HDL-), Low Density Lipoprotein (LDL-) cholesterol, glucose, triglycerides and uric acid levels, as well as of plasma total antioxidant capacity according to Ferric Reducing Antioxidant Power method, were determined between groups in fasting, thirty minutes, one and a half hour, and three hours after meal intake.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 13
Est. completion date January 15, 2024
Est. primary completion date October 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 65 Years
Eligibility Inclusion Criteria: - Age 19-65 years Exclusion Criteria: - Age over 65 years old - History of chronic illness including type I and II diabetes (hemoglobin A1c-HbA1c > 5%) - Abnormal Body Mass Index (BMI) (>25 kg/m2) - Alcohol overconsumption (>40 g alcohol/day) - Abnormal hematological and biochemical profiles (cholesterol > 6.8 mM, triglycerides > 2.8 mM, glucose > 6.11 mM)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Functional crackers enriched with grape seed flour
The crackers was enriched with 10% grape seed flour
Functional crackers with 40% barley flour and enriched with ß-glucans
The crackers consisted of 60% wheat flour, 40% barley flour and was enriched with ß-glucans.

Locations

Country Name City State
Greece University of the Aegean Myrina Limnos/Lesvos

Sponsors (1)

Lead Sponsor Collaborator
University of the Aegean

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Glucose Glucose concentration changes from baseline at 3hours 3 hours
Primary Total Antioxidant Capacity Total Antioxidant Capacity concentration changes from baseline at 3 hours 3 hours
Secondary Total cholesterol Total cholesterol concentration changes from baseline at 3hours 3 hours
Secondary High Density Lipoprotein cholesterol High Density Lipoprotein concentration cholesterol changes from baseline at 3hours 3 hours
Secondary Low Density Lipoprotein cholesterol Low Density Lipoprotein cholesterol concentration changes from baseline at 3hours 3 hours
Secondary Triglycerides Triglycerides concentration changes from baseline at 3hours 3 hours
Secondary Uric Acid Uric Acid concentration changes from baseline at 3hours 3 hours
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1